健保藥品的HTA評估報告
- 71 修訂重度持續性氣喘治療藥品omalizumab 成分藥品(如Xolair)及嗜伊紅性(嗜酸性)白血球的嚴重氣喘治療藥品mepolizumab(如Nucala)、benralizumab(如Fasenra)
- 72 Rinvoq Extended-Release Tablets 15 mg
- 73 達珂凍晶注射劑 (Dacogen® Powder for Concentrate for Solution for Infusion)
- 74 Demylocan lyophilized powder for injection
- 75 EYBELIS ophthalmic solution
- 76 利腸服注射劑 (Revestive injection)
- 77 Chenodexycholic acid
- 78 維萬心軟膠囊 (Vyndamax)
- 79 泰時維膜衣錠 (Ayvakit film-coated tablets)
- 80 Remsima Solution for Injection